Why prevent when it does not pay? Prevention when health services are credence goods

Health Economics
Felix C H Gottschalk

Abstract

This article identifies information asymmetries and the corresponding problem of overtreatment as a possible source of prevention and health disparities when patients differ with respect to their health risk. It analyzes preventive health behavior (primary prevention) and preventive health-care utilization (secondary prevention) in markets in which patients cannot determine whether they receive excessive secondary preventive treatment-that is, where health services are credence goods. The problem of overtreatment in such markets is considered as a possible pathway through which differences in health risk lead to disparities in primary and secondary prevention as well as the corresponding health outcomes. Patients with high health risks do not invest in primary prevention, because they anticipate to be provided with unnecessary secondary prevention. Patients with lower risks invest in primary but not in secondary prevention, resulting in health losses. Furthermore, when societal groups differ with respect to their exposure to overtreatment, and we consider socioeconomic status as a possible reason, we observe disparities in primary and secondary prevention as well as the resulting health outcomes, including the "social gradient....Continue Reading

References

Jan 1, 1995·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·T M Hassell, E L Harris
Mar 10, 1988·Economic Inquiry·D Dranove
Dec 11, 1999·Health Economics·P Calcott
Jan 10, 2001·Annual Review of Psychology·C MaslachM P Leiter
Jan 5, 2002·Journal of Health Economics·A I Balsa, T G McGuire
Jul 20, 2004·Health Economics·Eddy van DoorslaerAndrew M Jones
Jan 18, 2005·Patient Education and Counseling·S WillemsJ De Maeseneer
Dec 15, 2005·JAMA : the Journal of the American Medical Association·Paula A BravemanSamuel Posner
Nov 23, 2007·Annual Review of Public Health·Nancy E Adler, David H Rehkopf
Nov 11, 2008·Lancet·Michael MarmotUNKNOWN Commission on Social Determinants of Health
Dec 8, 2009·Journal of Health Economics·David M Cutler, Adriana Lleras-Muney
Dec 17, 2009·Journal of Health Economics·Kris De Jaegher
Jan 5, 2011·European Journal of Clinical Investigation·Christian Herder, Michael Roden
Feb 19, 2011·Science·James P EvansTimothy Caulfield
Jul 8, 2011·Journal of Health Economics·Janet CurrieWei Zhang
Sep 13, 2011·Annual Review of Sociology·Fred C PampelJustin T Denney
Mar 14, 2013·Annual Review of Economics·Daniel J BenjaminPaul Lichtenstein
Mar 22, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Giovannella BaggioVittorina Zagonel
Jun 19, 2013·Journal of Health Economics·David Bardey, Philippe De Donder
Aug 10, 2013·American Journal of Public Health·Daniel W BelskyAvshalom Caspi
Dec 18, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Marion Devaux
Jan 28, 2014·Journal of Health Economics·Lilia Filipova-Neumann, Michael Hoy
Oct 24, 2014·Health Economics·Christian Schmid
Oct 25, 2014·Biodemography and Social Biology·Daniel W Belsky, Salomon Israel
Dec 19, 2014·Health Economics·Mary K Hamman, Kandice A Kapinos
Jun 25, 2015·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·George L WehbyJason D Boardman
Jun 27, 2015·Global Health Action·Mariana C ArcayaS V Subramanian
Dec 7, 2017·Health Economics·Kurt R BrekkeOdd Rune Straume
Dec 1, 2016·The American Economic Review·Jishnu DasKarthik Muralidharan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revue D'épidémiologie Et De Santé Publique
N Sartorius
Cancer Prevention & Control : CPC = Prévention & Contrôle En Cancérologie : PCC
D Iverson
Läkartidningen
Lars RydénLinda Mellbin
Mental Health Today
Catherine Jackson
Archives of Internal Medicine
M D Bogdonoff
© 2022 Meta ULC. All rights reserved